Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes.
Sign Up to like & getrecommendations! Published in 2021 at "American heart journal"
DOI: 10.1016/j.ahj.2021.09.014
Abstract: BACKGROUND Stopping renin-angiotensin system inhibitors (RASi) after an episode of hyperkalemia is common but may involve therapeutic compromises, in that the cessation of RASi deprives patients of their beneficial cardiovascular effects. METHODS AND RESULTS Observational… read more here.
Keywords: risk; renin angiotensin; hyperkalemia; stopping renin ... See more keywords